Annual Drug Patent Expirations for INQOVI
Inqovi is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has forty-seven patent family members in thirty-nine countries.
The generic ingredient in INQOVI is cedazuridine; decitabine. One supplier is listed for this compound. Additional details are available on the cedazuridine; decitabine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com